Fasciola hepatica: Histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha

Veterinary Parasitology

Volumn 168, Issue 3-4, 2010, Pages 240-254

  Hanna, R E B ^a   Edgar, H W J ^a   McConnell, S ^a   Toner, E ^b   McConville, M ^b   Brennan, G P ^b   Devine, C ^b   Flanagan, A ^b   Halferty, L ^b   Meaney, M ^b   Shaw, L ^b   Moffett, D ^a   McCoy, M ^a   Fairweather, I ^b  

^a AGRI FOOD AND BIOSCIENCES INSTITUTE   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Compound Alpha; Fasciola hepatica; In vivo histology; Reproductive structures; TCBZ resistance; Triclabendazole

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; TRICLABENDAZOLE;

ANIMAL CELL; ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTHELMINTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL KINETICS; CYTOLOGY; DRUG EFFICACY; DRUG RESISTANCE; DRUG SENSITIVITY; FASCIOLA HEPATICA; FASCIOLIASIS; HISTOPATHOLOGY; IN VIVO STUDY; LAMB; MEIOSIS; METACERCARIA; MICROTUBULE ASSEMBLY; MITOSIS; NONHUMAN; OVARY FOLLICLE; PHARMACOLOGICAL BLOCKING; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE STUDY; TESTIS; TISSUE DISTRIBUTION; UTERUS; VITELLINE MEMBRANE; WORM EGG;

ANIMALS; ANTHELMINTICS; BENZIMIDAZOLES; DRUG RESISTANCE; FASCIOLA HEPATICA; FASCIOLIASIS; GENITALIA; IMIDAZOLES; NAPHTHALENES; SHEEP; SHEEP DISEASES; TIME FACTORS;

ANIMALIA; FASCIOLA HEPATICA; OVIS ARIES;

EID: 77349111491     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2009.11.014     Document Type: Article

References (42)

1. Bjorkman N., and Thorsell W. On the ultrastructure of the ovary of the liver fluke (Fasciola hepatica L.). Z. Zellforsch. Mikrosk. Anat. 63 (1964) 538-549
2. Boray J.C., Crowfoot P.D., Strong M.B., Allison J.R., Schellenbaum M., Orelli M., and Von Sarasin G. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Vet. Rec. 113 (1983) 315-317
3. Coles G.C., Rhodes A.C., and Stafford K.A. Activity of closantel against adult triclabendazole-resistant Fasciola hepatica. Vet. Rec. 146 (2000) 504
4. Coles G.C., and Stafford K.A. Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica. Vet. Rec. 148 (2001) 723-724
5. Fairweather I. Triclabendazole: new skills to unravel an old(ish) enigma. J. Helminthol. 79 (2005) 227-234
6. Fairweather I. Triclabendazole progress report, 2005-2009: an advancement of learning?. J. Helminthol. 83 (2009) 139-150
7. Fairweather I., and Boray J.C. Mechanisms of fasciolicide action and drug resistance in Fasciola hepatica. In: Dalton J.P. (Ed). Fasciolosis (1999), CABI Publishing, Wallingford, Oxon, UK 225-276 (Chapter 7)
8. Fairweather I., Threadgold L.T., and Hanna R.E.B. Development of Fasciola hepatica in the mammalian host. In: Dalton J.P. (Ed). Fasciolosis (1999), CABI Publishing, Wallingford, Oxon, UK 47-111 (Chapter 3)
9. Fletcher H.L., Hoey E.M., Orr N., Trudgett A., Fairweather I., and Robinson M.W. The occurrence and significance of triploidy in the liver fluke, Fasciola hepatica. Parasitology 128 (2004) 69-72
10. Gresson R.A.R. Electron microscopy of the ovary of Fasciola hepatica. Quart. J. Microsc. Sci. 105 (1964) 213-218
11. Halferty L., Brennan G.P., Hanna R.E.B., Edgar H.W., Meaney M.M., McConville M., Trudgett A., Hoey L., and Fairweather I. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole. Vet. Parasitol. 115 (2008) 49-58
12. Halferty L., Brennan G.P., Trudgett A., Hoey L., and Fairweather I. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica. Vet. Parasitol. 159 (2009) 126-138
13. Hanna R.E.B., Edgar H., Moffett D., McConnell S., Fairweather I., Brennan G.P., Trudgett A., Hoey E.M., Cromie L., Taylor S.M., and Daniel R. Fasciola hepatica: Histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally-infected hosts. Vet. Parasitol. 157 (2008) 222-234
14. Hennessy D.R., Lacey E., Steel J.W., and Prichard R.K. The kinetics of triclabendazole disposition in sheep. J. Vet. Pharmacol. Ther. 10 (1987) 64-72
15. Hernández-Campos A., Ibarra-Velarde F., Vera-Montenegro Y., Rivera-Fernandez N., and Castillo R. Synthesis and fasciolicidal activity of 5-chloro-2-methylthio-6-(1-naphthyloxy)-1H-benzimidazole. Chem. Pharm. Bull. 50 (2002) 649-652
16. Ibarra V.F., García S.E., Fernández R.M., Vera M.Y., Castillo B.R., and Hernández C.A. Eficacia fasciolicida de dos compuestos de síntesis química in vitro e in vivo en ovinos. Vet. Méx. 28 (1997) 291-296
17. Ibarra V.F., Vera M.Y., Hernández C.A., and Castillo B.R. Eficacia fasciolicida del compuesto "alfa" contra estadios juveniles y adultos en ovinos. Vet. Méx. 28 (1997) 297-301
18. Ibarra V.F., Montenegro C.N., Flores C.J., Hernández C.A., and Castillo B.R. Evaluacíon de cuatro vehículos para formular un fasciolicida experimental. Vet. Méx. 31 (2000) 47-51
19. Irwin S.W.B., and Threadgold L.T. Electron-microscope studies on Fasciola hepatica. VIII. The development of the vitelline cells. Exp. Parasitol. 28 (1970) 399-411
20. Kumar V., Abbas A.K., and Fausto N. Robbins and Cotran Pathologic Basis of Disease. seventh ed (2005), Elsevier Saunders, Philadelphia, Pennsylvania, USA pp 26-32
21. Lacey E. The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int. J. Parasitol. 18 (1988) 885-936
22. Meaney M., Fairweather I., Brennan G.P., Ramasamy P., and Subramanian P.B. Fasciola gigantica: tegumental surface alterations following treatment in vitro with the sulphoxide metabolite of triclabendazole. Parasitol. Res. 88 (2002) 315-325
23. McConville M., Brennan G.P., McCoy M., Castillo R., Hernández-Campos A., Ibarra F., and Fairweather I. Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha. Parasitology 133 (2006) 195-208
24. McConville M., Brennan G.P., McCoy M., Castillo R., Hernández-Campos A., Ibarra F., and Fairweather I. Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha. Parasitol. Res. 100 (2007) 365-377
25. McConville M., Brennan G.P., Flanagan A., Edgar H.W.J., McCoy M., Castillo R., Hernández-Campos A., and Fairweather I. Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha. Vet. Parasitol. 153 (2008) 52-64
26. McConville M., Brennan G.P., Flanagan A., Edgar H.W.J., Hanna R.E.B., McCoy M., Gordon A.W., Castillo R., Hernández-Campos A., and Fairweather I. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica. Vet. Parasitol. 162 (2009) 75-88
27. McConville M., Brennan G.P., Edgar H.W.J., Castillo R., Hernández-Campos A., and Fairweather I. Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha. Parasitology 136 (2009) 655-680
28. McConville M., Brennan G.P., Flanagan A., Hanna R.E.B., Edgar H.W.J., Castillo R., Hernández-Campos A., and Fairweather I. Surface changes in adult Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha. Parasitol. Res. 105 (2009) 757-767
29. McConville M., Hanna R.E.B., Brennan G.P., McCoy M., Edgar H.W.J., McConnell S., Moffett M., Castillo R., Hernández-Campos A., and Fairweather I. Fasciola hepatica: disruption of spermatogenesis by the fasciolicide, compound alpha. Parasitol. Res. 106 (2010) 311-323
30. McCoy M.A., Fairweather I., Brennan G.P., Kenny J.M., Ellison S., and Forbes A.B. The efficacy of nitroxynil and triclabendazole administered synchronously against juvenile triclabendazole-resistant Fasciola hepatica in sheep. Res. Vet. Sci. 78 Suppl. A (2005) 33
31. Overend D.J., and Bowen F.L. Resistance of Fasciola hepatica to triclabendazole. Aust. Vet. J. 72 (1995) 275-276
32. Ramírez N., Mayet L., Del Rivero L., Ibarra-Velarde F., Castillo R., Hernández-Campos A., and Jung-Cook H. Pharmacokinetic behaviour in sheep and cattle of 5-chloro-2-(methylthio)-6-(1-naphthyloxy)-1H-benzimidazole, a new fasciolicide agent. J. Vet. Pharmacol. Ther. 32 (2009) 154-159
33. Rivera F.N., Ibarra V.F., Olazaràn J.S., Vera M.Y., Castillo B.R., and Hernández C.A. Efficacy of 5-chloro-2-methylthio-6-(1-naftiloxi)-ih-benzimidazole against different stages of Fasciola hepatica in Pelibuey sheep. Vet. Méx. 33 (2002) 55-61
34. Smyth J.D., and Halton D.W. The Physiology of Trematodes. second ed. (1983), Cambridge University Press, Cambridge, UK p. 446
35. Stitt A.W., and Fairweather I. Spermatogenesis and the fine structure of the mature spermatozoon of the liver fluke, Fasciola hepatica (Trematoda: Digenea). Parasitology 101 (1990) 395-407
36. Stitt A.W., and Fairweather I. Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole ('Fasinex'). Parasitol. Res. 79 (1993) 529-536
37. Stitt A.W., Fairweather I., and Mackender R.O. The effect of triclabendazole ('Fasinex') on protein synthesis by the liver fluke, Fasciola hepatica. Int. J. Parasitol. 25 (1995) 421-429
38. Threadgold L.T. Fasciola hepatica: stereological analysis of vitelline cell development. Exp. Parasitol. 54 (1982) 352-365
39. Threadgold L.T., and Irwin S.W.B. Electron microscope studies of Fasciola hepatica IX. The fine structure of Mehlis' gland. Z. Parasitkde 35 (1970) 16-30
40. Vera-Montenegro Y., Ibarra V.F., Quiroz R.H., Hernández C.A., and Castillo B.R. Field trial on the efficacy of an experimental fasciolicide compared with some commercial compounds in naturally infected cattle. Parasitol. Res. 91 (2003) 1-4
41. Vera-Montenegro Y., Ibarra V.F., Liébano H.E., Quiroz R.H., Castillo B.R., Hernández C.A., and Ochoa G.P. Efficacy of an experimental fasciolicide against immature and mature Fasciola hepatica in artificially infected calves. Parasitol. Res. 92 (2004) 211-214
42. Walker S.M., McKinstry B., Boray J.C., Brennan G.P., Trudgett A., Hoey E.M., Fletcher H., and Fairweather I. Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro. Parasitol. Res. 94 (2004) 427-438